Minimum Residual Disease in Acute Lymphoblastic Leukemia
5 意见
• 08/04/23
0
0
嵌入
In this segment, Jeffrey Lancet, MD; Raoul Tibes, MD; and Mark R. Litzow, MD, describe various methodologies in monitoring minimum residual disease in acute lymphoblastic leukemia.
显示更多
脸书评论
SORT BY-
热门评论
-
最新评论